Inetetamab
Inetetamab is 3SBio's HER2 antibody, approved in China in 2020 with vinorelbine for HER2-positive metastatic breast cancer.
Overview
Inetetamab (Cipterbin) is a HER2 antibody developed by 3SBio in Shenyang with an engineered Fc region for stronger antibody-dependent cellular cytotoxicity. The NMPA approved it in June 2020 in combination with vinorelbine for HER2-positive metastatic breast cancer previously treated with chemotherapy, making it the first HER2 antibody developed in China.
Binds HER2 on tumour cells, blocking growth signals and recruiting immune cells; its modified Fc region strengthens antibody-dependent cell killing compared with trastuzumab. Connects to HER2.
1.Inetetamab binds HER2.
Compare all products across the US, EU, UK, Japan, China and Australia →
Approvals
| Region | Year | Indication |
|---|---|---|
| CN | 2020 | HER2-positive metastatic breast cancer after chemotherapy, with vinorelbine |
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Inetetamab" OR ABSTRACT:"Inetetamab" OR TITLE:"Cipterbin" OR ABSTRACT:"Cipterbin") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Inetetamab, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentBenmelstobart
Shares the tags china, nmpa-approved.
- TreatmentFlumatinib
Shares the tags china, nmpa-approved.
- TreatmentGumarontinib
Shares the tags china, nmpa-approved.
- TreatmentH101 oncolytic adenovirus
Shares the tags china, nmpa-approved.
- TreatmentIparomlimab and tuvonralimab
Shares the tags china, nmpa-approved.
- TreatmentIruplinalkib
Shares the tags china, nmpa-approved.
- TreatmentLinperlisib
Shares the tags china, nmpa-approved.
- TreatmentMecapegfilgrastim
Shares the tags china, nmpa-approved.